#$%^&*AU2013204181A120130516.pdf#####The present invention relates to methods and compositions for the treatment of proliferative diseases comprising the administration of a combination of a taxane and at least one other and other therapeutic agents, as well as other treatment modalities useful in the treatment of proliferative diseases. In particular, the invention relates to the use of nanoparticles comprising paclitaxel and albumin (such as Abraxane*) in combination with other chemotherapeutic agents or radiation, which may be used for the treatment of cancer.
